Betamab ApS
CVR number: 40337326
Hørsholmvej 11, Langstrup 3050 Humlebæk
soren@betamab.com
tel: 24243575
www.betamab.com
Income statement (kDKK)
| 2019 | 2020 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | - 343.39 | - 736.48 |
| Employee benefit expenses | -1 007.92 | |
| EBIT | - 343.39 | -1 744.40 |
| Other financial expenses | -0.69 | -3.90 |
| Pre-tax profit | - 344.08 | -1 748.30 |
| Income taxes | 75.70 | 384.61 |
| Net earnings | - 268.38 | -1 363.69 |
Assets (kDKK)
| 2019 | 2020 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Other receivables | -0.00 | |
| Investments total | -0.00 | |
| Long term receivables total | ||
| Inventories total | ||
| Current trade debtors | 45.72 | |
| Prepayments and accrued income | 6.97 | |
| Current other receivables | 84.75 | 25.23 |
| Current deferred tax assets | 75.55 | 384.76 |
| Short term receivables total | 160.30 | 462.68 |
| Cash and bank deposits | 50.31 | 278.29 |
| Cash and cash equivalents | 50.31 | 278.29 |
| Balance sheet total (assets) | 210.61 | 740.97 |
Equity and liabilities (kDKK)
| 2019 | 2020 | |
|---|---|---|
| Share capital | 51.00 | 53.78 |
| Retained earnings | 1 728.84 | |
| Profit of the financial year | - 268.38 | -1 363.69 |
| Shareholders equity total | - 217.38 | 418.93 |
| Non-current other liabilities | 10.50 | |
| Non-current liabilities total | 10.50 | |
| Current trade creditors | 427.99 | 35.23 |
| Other non-interest bearing current liabilities | 276.31 | |
| Current liabilities total | 427.99 | 311.54 |
| Balance sheet total (liabilities) | 210.61 | 740.97 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.